2022. Laboratory assessment of liver function in people starting antiretroviral therapy with Dolutegravir or Efavirenz: a cohort study in Belo Horizonte, Brazil. Research, Society and Development. 11, 13 (Sep. 2022), e74111335082. DOI:https://doi.org/10.33448/rsd-v11i13.35082.